Keyphrases
Cost-effectiveness
100%
Topiramate
100%
Pharmacotherapy
100%
Phentermine
100%
Obesity in Adolescents
100%
Obesity Treatment
100%
Quality-adjusted Life Years
58%
Lifestyle Counseling
58%
Semaglutide
33%
Incremental Cost-effectiveness Ratio
33%
Liraglutide
25%
Life-years Gained
25%
Economic Evaluation
16%
Adolescents with Obesity
16%
Clinical Trials
8%
Obesity
8%
Adolescent Age
8%
Weight Loss
8%
Health Outcomes
8%
Adolescent Substance Use
8%
Adulthood
8%
Adolescent Patients
8%
Weight Reduction
8%
Microsimulation Model
8%
U.S. Food
8%
Cost Outcomes
8%
Parameter Uncertainty
8%
Project Cost
8%
Loss Reduction
8%
BMI Index
8%
Probabilistic Sensitivity Analysis
8%
Patients with Obesity
8%
Long-term Clinical Study
8%
One-way Sensitivity Analysis
8%
Project Health
8%
Obesity Pharmacotherapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Topiramate
100%
Phentermine
100%
Semaglutide
33%
Liraglutide
25%
Clinical Trial
16%